Eli Lilly strengthens immunology business with billion-dollar acquisition
The US pharmaceutical company is acquiring Merida Biosciences and is continuing its buying spree. The race in the market for weight loss medications is getting tighter.
We haven't written up this one. Der Standard Wirtschaft has the full story — the link below goes straight to it.